Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
A Creemers1,2, E Ter Veer3, L de Waal3
1Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, AMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. a.creemers@amc.uva.nl.
Abstract:
Trastuzumab combined with chemotherapy is standard of care for HER2 positive advanced gastro-esophageal cancers. The reported prevalence of HER2 discordance between primary tumors and corresponding metastases varies, hampering uniform patient selection for HER2 targeted therapy. This meta-analysis explores the influence of HER2 assessment methods on this discordance and investigates the prevalence of HER2 discordance in gastro-esophageal adenocarcinomas. PubMed, Embase and Cochrane databases were searched until January 2016. Differences in discordance rate between strict and broad(er) definitions of HER2 status were assessed using random-effect pair-wise meta-analysis. Random-effect single-arm meta-analyses were performed to assess HER2 discordance and the prevalence of positive and negative conversion. A significantly lower discordance rate in HER2 status between primary tumors and corresponding metastases was observed using a strict vs. broad definition of HER2 status (RR = 0.58, 95%CI 0.41-0.82), with a pooled discordance rate of 6.2% and 12.2%, respectively. Using the strict definition of HER2 assessment pooled overall discordance was 7% (95%CI 5-10%). The lowest discordance rates between primary tumors and corresponding metastasis are observed when using a strict method of HER2 positivity. Treatment outcomes of different studies will be better comparable if selection of eligible patients for HER2 targeted therapy is based on this strict definition.
Insights
A strict definition for human epidermal growth factor receptor 2 (HER2) positivity reduces discordance between primary tumors and metastases in gastro-esophageal cancers. This improves patient selection for HER2-targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Trastuzumab plus chemotherapy is standard for HER2-positive advanced gastro-esophageal cancers.
- HER2 discordance between primary tumors and metastases complicates patient selection for targeted therapy.
Purpose of the Study:
- To explore how HER2 assessment methods influence discordance rates.
- To investigate the prevalence of HER2 discordance in gastro-esophageal adenocarcinomas.
Main Methods:
- Systematic literature search of PubMed, Embase, and Cochrane databases (until January 2016).
- Random-effect meta-analyses to compare discordance rates between strict and broad HER2 definitions.
- Random-effect single-arm meta-analyses to assess overall HER2 discordance and conversion rates.
Main Results:
- A strict HER2 definition significantly lowered discordance rates (RR=0.58) compared to broader definitions (6.2% vs. 12.2% pooled discordance).
- Overall pooled discordance using the strict definition was 7% (95% CI 5-10%).
- Lowest discordance observed with strict HER2 positivity assessment.
Conclusions:
- Strict HER2 assessment methods minimize discordance between primary tumors and metastases.
- Standardizing patient selection for HER2-targeted therapy using a strict definition enhances comparability of treatment outcomes across studies.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
